A good outcome for a case of chronic pneumonitis of infancy

Jong Min Kim1, Seung Yeon Kwon, Eun Soo Kim

  • 1Department of Pediatrics and Institute of Allergy, Yonsei University College of Medicine, Severance Hospital, 250 Seongsanno, Seodaemun-gu, Seoul, Korea.

Yonsei Medical Journal
|October 30, 2007
PubMed

Insights

Chronic pneumonitis of infancy (CPI) is a rare, serious lung disease in infants. This case study shows a 3-month-old girl improved with proper treatment for this challenging condition.

Area of Science:

  • Pediatric Pulmonology
  • Rare Diseases
  • Interstitial Lung Disease

Background:

  • Chronic pneumonitis of infancy (CPI) is an uncommon and severe interstitial lung disease affecting infants.
  • CPI presents distinct pathological features compared to other pneumonias in pediatric and adult populations.
  • High mortality rates are associated with CPI, even with therapeutic interventions.

Observation:

  • A 3-month-old female infant presented with symptoms indicative of a severe respiratory condition.
  • Diagnostic evaluation included an open lung biopsy to ascertain the underlying pathology.
  • The infant was diagnosed with chronic pneumonitis of infancy.

Findings:

  • The patient's lung biopsy revealed pathological characteristics consistent with CPI.
  • Following diagnosis, the infant received appropriate medical treatment tailored to CPI.
  • The infant demonstrated significant clinical improvement after the initiation of proper treatment.

Implications:

  • This case highlights the importance of early diagnosis and appropriate management of CPI.
  • Successful treatment of CPI, even in severe cases, is achievable with targeted therapies.
  • Further research into CPI pathogenesis and treatment strategies is warranted to improve infant outcomes.

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...